The FDA's Center for Biologics Evaluation and Research is planning to release some crucial guidance soon for CRISPR and gene therapy developers on platform technologies, accelerated ...
READ MOREPharma companies set for Cannes ad creativity festival: Pfizer and Novo Nordisk are both set to take the main stages at Cannes' advertising confab this summer. The just-announced ...
READ MOREImmunityBio scored an FDA approval for its once-rejected drug combo for bladder cancer, the biotech announced Monday, sending its stock up nearly 25% in premarket trading.
READ MORESamsung Biologics’ Plant 4 remains a worthwhile $2 billion investment.
READ MORE